197 related articles for article (PubMed ID: 11985972)
21. Randomized Trial of Prophylactic Antibiotics for Endoscopic Retrograde Cholangiopancreatography in Patients With Biliary Obstruction.
Leem G; Sung MJ; Park JH; Kim SJ; Jo JH; Lee HS; Ku NS; Park JY; Bang S; Park SW; Song SY; Chung MJ
Am J Gastroenterol; 2024 Jan; 119(1):183-190. PubMed ID: 37713527
[TBL] [Abstract][Full Text] [Related]
22. Frequency of post-ERCP pancreatitis in a single tertiary referral centre without and with routine prophylaxis with gabexate: a 6-year survey and cost-effectiveness analysis.
Testoni PA; Mariani A; Masci E; Curioni S
Dig Liver Dis; 2006 Aug; 38(8):588-95. PubMed ID: 16731060
[TBL] [Abstract][Full Text] [Related]
23. Nasobiliary drainage can reduce the incidence of post-ERCP pancreatitis after papillary large balloon dilation plus endoscopic biliary sphincterotomy: a randomized controlled trial.
Huang Q; Shao F; Wang C; Qi W; Qiu LJ; Liu Z
Scand J Gastroenterol; 2018 Jan; 53(1):114-119. PubMed ID: 29043861
[TBL] [Abstract][Full Text] [Related]
24. Preoperative versus postoperative endoscopic retrograde cholangiopancreatography in mild to moderate gallstone pancreatitis: a prospective randomized trial.
Chang L; Lo S; Stabile BE; Lewis RJ; Toosie K; de Virgilio C
Ann Surg; 2000 Jan; 231(1):82-7. PubMed ID: 10636106
[TBL] [Abstract][Full Text] [Related]
25. Interleukin 10 reduces the incidence of pancreatitis after therapeutic endoscopic retrograde cholangiopancreatography.
Devière J; Le Moine O; Van Laethem JL; Eisendrath P; Ghilain A; Severs N; Cohard M
Gastroenterology; 2001 Feb; 120(2):498-505. PubMed ID: 11159890
[TBL] [Abstract][Full Text] [Related]
26. Low-molecular-weight heparin does not prevent acute post-ERCP pancreatitis.
Rabenstein T; Fischer B; Wiessner V; Schmidt H; Radespiel-Tröger M; Hochberger J; Mühldorfer S; Nusko G; Messmann H; Schölmerich J; Schulz HJ; Schönekäs H; Hahn EG; Schneider HT
Gastrointest Endosc; 2004 May; 59(6):606-13. PubMed ID: 15114301
[TBL] [Abstract][Full Text] [Related]
27. Effect of somatostatin in the prevention of pancreatic complications after endoscopic retrograde cholangiopancreatography.
Chan HH; Lai KH; Lin CK; Tsai WL; Lo GH; Hsu PI; Wei MC; Wang EM
J Chin Med Assoc; 2008 Dec; 71(12):605-9. PubMed ID: 19114324
[TBL] [Abstract][Full Text] [Related]
28. Pancreatic stents for the prevention of post-endoscopic retrograde cholangiopancreatography pancreatitis should be inserted up to the pancreatic body or tail.
Sugimoto M; Takagi T; Suzuki R; Konno N; Asama H; Sato Y; Irie H; Watanabe K; Nakamura J; Kikuchi H; Waragai Y; Takasumi M; Hikichi T; Ohira H
World J Gastroenterol; 2018 Jun; 24(22):2392-2399. PubMed ID: 29904246
[TBL] [Abstract][Full Text] [Related]
29. Nasobiliary drainage after endoscopic papillary balloon dilatation may prevent postoperative pancreatitis.
Xu XD; Dai JJ; Qian JQ; Wang WJ
World J Gastroenterol; 2015 Feb; 21(8):2443-9. PubMed ID: 25741153
[TBL] [Abstract][Full Text] [Related]
30. The effect of octreotide on the prevention of acute pancreatitis and hyperamylasemia after diagnostic and therapeutic ERCP.
Arvanitidis D; Hatzipanayiotis J; Koutsounopoulos G; Frangou E
Hepatogastroenterology; 1998; 45(19):248-52. PubMed ID: 9496522
[TBL] [Abstract][Full Text] [Related]
31. No Benefit of Oral Diclofenac on Post-Endoscopic Retrograde Cholangiopancreatography Pancreatitis.
Ishiwatari H; Urata T; Yasuda I; Matsusaki S; Hisai H; Kawakami H; Ono M; Iwashita T; Doi S; Kawakubo K; Hayashi T; Sonoda T; Sakamoto N; Kato J
Dig Dis Sci; 2016 Nov; 61(11):3292-3301. PubMed ID: 27447477
[TBL] [Abstract][Full Text] [Related]
32. Prospective assessment of the role of antibiotic prophylaxis in ERCP.
Llach J; Bordas JM; Almela M; Pellisé M; Mata A; Soria M; Fernández-Esparrach G; Ginès A; Elizalde JI; Feu F; Piqué JM
Hepatogastroenterology; 2006; 53(70):540-2. PubMed ID: 16995457
[TBL] [Abstract][Full Text] [Related]
33. NIH state-of-the-science statement on endoscopic retrograde cholangiopancreatography (ERCP) for diagnosis and therapy.
NIH Consens State Sci Statements; 2002 Jan 14-16; 19(1):1-26. PubMed ID: 14768653
[TBL] [Abstract][Full Text] [Related]
34. Neutrophil activation and hyperamylasaemia after endoscopic retrograde cholangiopancreatography: potential role for the leukocyte in the pathogenesis of acute pancreatitis.
Mann DV; Kalu P; Foulds S; Edwards R; Glazer G
Endoscopy; 2001 May; 33(5):448-53. PubMed ID: 11396766
[TBL] [Abstract][Full Text] [Related]
35. Urgent endoscopic retrograde cholangiopancreatography with sphincterotomy versus conservative treatment in predicted severe acute gallstone pancreatitis (APEC): a multicentre randomised controlled trial.
Schepers NJ; Hallensleben NDL; Besselink MG; Anten MGF; Bollen TL; da Costa DW; van Delft F; van Dijk SM; van Dullemen HM; Dijkgraaf MGW; van Eijck CHJ; Erkelens GW; Erler NS; Fockens P; van Geenen EJM; van Grinsven J; Hollemans RA; van Hooft JE; van der Hulst RWM; Jansen JM; Kubben FJGM; Kuiken SD; Laheij RJF; Quispel R; de Ridder RJJ; Rijk MCM; Römkens TEH; Ruigrok CHM; Schoon EJ; Schwartz MP; Smeets XJNM; Spanier BWM; Tan ACITL; Thijs WJ; Timmer R; Venneman NG; Verdonk RC; Vleggaar FP; van de Vrie W; Witteman BJ; van Santvoort HC; Bakker OJ; Bruno MJ;
Lancet; 2020 Jul; 396(10245):167-176. PubMed ID: 32682482
[TBL] [Abstract][Full Text] [Related]
36. Combined rectal indomethacin and intravenous saline hydration in post-ERCP pancreatitis prophylaxis.
Makhzangy HE; Samy S; Shehata M; Albuhiri A; Khairy A
Arab J Gastroenterol; 2022 May; 23(2):95-101. PubMed ID: 35153177
[TBL] [Abstract][Full Text] [Related]
37. Adverse events associated with ERCP.
; Chandrasekhara V; Khashab MA; Muthusamy VR; Acosta RD; Agrawal D; Bruining DH; Eloubeidi MA; Fanelli RD; Faulx AL; Gurudu SR; Kothari S; Lightdale JR; Qumseya BJ; Shaukat A; Wang A; Wani SB; Yang J; DeWitt JM
Gastrointest Endosc; 2017 Jan; 85(1):32-47. PubMed ID: 27546389
[No Abstract] [Full Text] [Related]
38. Predictors of successful clinical and laboratory outcomes in patients with primary sclerosing cholangitis undergoing endoscopic retrograde cholangiopancreatography.
Enns R; Eloubeidi MA; Mergener K; Jowell PS; Branch MS; Baillie J
Can J Gastroenterol; 2003 Apr; 17(4):243-8. PubMed ID: 12704468
[TBL] [Abstract][Full Text] [Related]
39. Gabexate or somatostatin administration before ERCP in patients at high risk for post-ERCP pancreatitis: a multicenter, placebo-controlled, randomized clinical trial.
Andriulli A; Clemente R; Solmi L; Terruzzi V; Suriani R; Sigillito A; Leandro G; Leo P; De Maio G; Perri F
Gastrointest Endosc; 2002 Oct; 56(4):488-95. PubMed ID: 12297762
[TBL] [Abstract][Full Text] [Related]
40. Predictors of complications after endoscopic retrograde cholangiopancreatography: a prognostic model for early discharge.
Jeurnink SM; Siersema PD; Steyerberg EW; Dees J; Poley JW; Haringsma J; Kuipers EJ
Surg Endosc; 2011 Sep; 25(9):2892-900. PubMed ID: 21455806
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
